Valeritas Holdings Inc is a commercial-stage medical technology company. It is engaged in the business of improving health and simplifying life for diabetic patients by developing and commercializing innovative technologies.
Stock Price Prediction
Update at 5:00pm EST
1.503 - 1.511
1.511 - 1.521
1.426 - 1.436
1.436 - 1.446
1.462 - 1.479
1.479 - 1.497
as of: 2019-11-19 4:30:53 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.VLRX has closed above bottom band by 46.7%. Bollinger Bands are 77.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to VLRX's normal range. The bands have been in this narrow range for 57 bars. This is a sign that the market may be about to initiate a new trend.
2019-07-30 Valeritas Rallies On Positive Preclinical Data For CBD Delivery Using Wearable Device Valeritas Holdings Inc (NASDAQ: VLRX ) shares have shed more than 61% in the year-to-date period. The stock is picking up some momentum Tuesday following a pre-clinical data readout from the medical technology company. What Happened Valeritas, which makes the V-Go – Wearable Insulin Delivery Device using its proprietary h-Patch technology, announced positive results from a preclinical pharmacokinetic study of cannabidiol subcutaneous infusion with two dosing regimens delivered using its proprietary h-Patch wearable drug delivery device. The study evaluated CBD delivered over a single 24-hour period using the h-Patch, with two doses: 40mg/24 hour and 76mg/24 hour tested using the patch. The pharmacokinetics … Full story available on Benzinga.com
2019-07-10 Valeritas Insulin Device For Diabetics Accepted Under Managed Formulary Valeritas Holdings (NASDAQ: VLRX ) shares are trading higher after the company on Tuesday afternoon announced its V-Go wearable insulin device has been adopted on multiple managed care formularies. The V-Go is a disposable device for the delivery of … Full story available on Benzinga.com
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.